2010•Dalian Yike Daxue xuebaoRequires access

Study of characteristics of ambulatory blood pressure in Telmisartan treated renal hypertension

Shulan Zhang

Open publisher page 0 citations

Abstract

[Objective] To evaluate the effect of telmisartan in mild and moderate renal hypertension by ambulatory blood pressure.[Methods] Eight-nine patients with mild to moderate renal hypertension were treated with 80 mg telmisartan once a day for 4 weeks.Twenty-four hour ambulatory blood pressure was monitored before and after telmisartan taken.Average blood pressure of 24 h,daytime,night-time,blood pressure load,blood pressure variability and circadian rhythm of blood pressure.[Results] After 4 weeks of telmisartan treatment,average SBP and DBP of 24 h,daytime,night-time,blood pressure load values,blood pressure variability were significant different from those in pre-treatment(P0.01).Night-time decline rate of SBP,DBP after treatment were statistically significant(P0.01 or 0.05) more than that before treatment [(10±9)% vs(2±8)% and(8±10)% vs(3±13)%].[Conclusion] Telmisartan in patients with mild to moderate renal hypertension is effective,smooth and can restore blood pressure circadian rhythm.

About this research paper

What this paper is about

[Objective] To evaluate the effect of telmisartan in mild and moderate renal hypertension by ambulatory blood pressure.[Methods] Eight-nine patients with mild to moderate renal hypertension were treated with 80 mg telmisartan once a day for 4 weeks.Twenty-four hour ambulatory blood pressure was monitored before and after telmisartan taken.Average blood pressure of 24 h,daytime,night-time,blood pressure load,blood pressure variability and circadian rhythm of blood pressure.[Results] After 4 weeks of telmisartan treatment,average SBP and DBP of 24 h,daytime,night-time,blood pressure load values,blood pressure variability were significant different from those in pre-treatment(P0.01).Night-time decline rate of SBP,DBP after treatment were statistically significant(P0.01 or 0.05) more than that before treatment [(10±9)% vs(2±8)% and(8±10)% vs(3±13)%].[Conclusion] Telmisartan in patients with mild to moderate renal hypertension is effective,smooth and can restore blood pressure circadian rhythm.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective] To evaluate the effect of telmisartan in mild and moderate renal hypertension by ambulatory blood pressure.[Methods] Eight-nine patients with mild to moderate renal hypertension were treated with 80 mg telmisartan once a day for 4 weeks.Twenty-four hour ambulatory blood pressure was monitored before and after telmisartan taken.Average blood pressure of 24 h,daytime,night-time,blood pressure load,blood pressure variability and circadian rhythm of blood pressure.[Results] After 4 weeks of telmisartan treatment,average SBP and DBP of 24 h,daytime,night-time,blood pressure load values,blood pressure variability were significant different from those in pre-treatment(P0.01).Night-time decline rate of SBP,DBP after treatment were statistically significant(P0.01 or 0.05) more than that before treatment [(10±9)% vs(2±8)% and(8±10)% vs(3±13)%].[Conclusion] Telmisartan in patients with mild to moderate renal hypertension is effective,smooth and can restore blood pressure circadian rhythm.

Key concepts: Telmisartan, Blood pressure, Ambulatory blood pressure, Medicine, Circadian rhythm, Internal medicine, Cardiology, Ambulatory

Related papers

Back to paper searchBrowse research topicsOriginal source
Study of characteristics of ambulatory blood pressure in Telmisartan treated renal hypertension — Research Paper | ScholarLens